中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
16期
77-78
,共2页
左旋甲状腺素%亚临床甲状腺功能减退%血脂
左鏇甲狀腺素%亞臨床甲狀腺功能減退%血脂
좌선갑상선소%아림상갑상선공능감퇴%혈지
Levothyroxine%Subclinical hypothyroidism%Blood fat
目的探讨左旋甲状腺素对亚临床甲状腺功能减退症的治疗效果以及对患者血脂水平的影响。方法将134例患者随机分为治疗组和对照组各67例,治疗组给予左旋甲状腺素治疗,对照组给予六味地黄丸进行治疗,观察两组患者的治疗效果及血脂变化。结果治疗组总有效率为91.0%,明显高于对照组53.7%,两组比较差异具有统计学意义(P<0.05);治疗组TG、TC、LDL均较治疗前有明显改善(P<0.05),HDL无明显变化(P>0.05);且治疗组TG、TC、LDL指标改善情况明显优于对照组,差异具有统计学意义(P<0.05),两组HDL比较,差异无统计学意义(P>0.05)。结论左旋甲状腺素可改善亚临床甲状腺减退患者的临床症状,降低血脂,提高患者的生活质量。
目的探討左鏇甲狀腺素對亞臨床甲狀腺功能減退癥的治療效果以及對患者血脂水平的影響。方法將134例患者隨機分為治療組和對照組各67例,治療組給予左鏇甲狀腺素治療,對照組給予六味地黃汍進行治療,觀察兩組患者的治療效果及血脂變化。結果治療組總有效率為91.0%,明顯高于對照組53.7%,兩組比較差異具有統計學意義(P<0.05);治療組TG、TC、LDL均較治療前有明顯改善(P<0.05),HDL無明顯變化(P>0.05);且治療組TG、TC、LDL指標改善情況明顯優于對照組,差異具有統計學意義(P<0.05),兩組HDL比較,差異無統計學意義(P>0.05)。結論左鏇甲狀腺素可改善亞臨床甲狀腺減退患者的臨床癥狀,降低血脂,提高患者的生活質量。
목적탐토좌선갑상선소대아림상갑상선공능감퇴증적치료효과이급대환자혈지수평적영향。방법장134례환자수궤분위치료조화대조조각67례,치료조급여좌선갑상선소치료,대조조급여륙미지황환진행치료,관찰량조환자적치료효과급혈지변화。결과치료조총유효솔위91.0%,명현고우대조조53.7%,량조비교차이구유통계학의의(P<0.05);치료조TG、TC、LDL균교치료전유명현개선(P<0.05),HDL무명현변화(P>0.05);차치료조TG、TC、LDL지표개선정황명현우우대조조,차이구유통계학의의(P<0.05),량조HDL비교,차이무통계학의의(P>0.05)。결론좌선갑상선소가개선아림상갑상선감퇴환자적림상증상,강저혈지,제고환자적생활질량。
Objective To explore the treatment effect of levothyroxine for subclinical hypothyroidism and its effect on lipid levels. Methods 134 cases were randomly divided into treatment group and control group, reach group had 67 cases, the treatment group received levothyroxine treatment, the control group treated with liuwei dihuang pill, observed the therapeutic effect and blood lipid changes of two groups. Results The total effective rate of the treatment group was 91.0%, significantly higher than the control group 53.7%, compared with two groups ,the difference was significant(P<0.05).TG,TC,LDL of treatment group was significantly improved than before treatment(P<0.05), there was no significant changes in HDL(P > 0.05).TG,TC,LDL and other indicators improved the situation significantly better than the control group , the difference has statistics significance(P < 0.05). Conclusion Levothyroxine can improve clinical symptoms of subclinical hypothyroidism, lower blood lipids, improve the patient's quality of life.